Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score.
Johnson PW, Kunze KL, Senefeld JW, Sinclair JE, Isha S, Satashia PH, Bhakta S, Cowart JB, Bosch W, O'Horo J, Shah SZ, Wadei HM, Edwards MA, Pollock BD, Edwards AJ, Scheitel-Tulledge S, Clune CG, Hanson SN, Arndt R, Heyliger A, Kudrna C, Bierle DM, Buckmeier JR, Seville MTA, Orenstein R, Libertin C, Ganesh R, Franco PM, Razonable RR, Carter RE, Sanghavi DK, Speicher LL. Johnson PW, et al. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr;7(2):109-121. doi: 10.1016/j.mayocpiqo.2022.12.007. Epub 2023 Jan 11. Mayo Clin Proc Innov Qual Outcomes. 2023. PMID: 36644593 Free PMC article.
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research.
O'Horo JC, Cerhan JR, Cahn EJ, Bauer PR, Temesgen Z, Ebbert J, Abril A, Abu Saleh OM, Assi M, Berbari EF, Bierle DM, Bosch W, Burger CD, Cano Cevallos EJ, Clements CM, Carmona Porquera EM, Castillo Almeida NE, Challener DW, Chesdachai S, Comba IY, Corsini Campioli CG, Crane SJ, Dababneh AS, Enzler MJ, Fadel HJ, Ganesh R, De Moraes AG, Go JR, Gordon JE, Gurram PR, Guru PK, Halverson EL, Harrison MF, Heaton HA, Hurt R, Kasten MJ, Lee AS, Levy ER, Libertin CR, Mallea JM, Marshall WF 3rd, Matcha G, Meehan AM, Franco PM, Morice WG 2nd, O'Brien JJ, Oeckler R, Ommen S, Oravec CP, Orenstein R, Ough NJ, Palraj R, Patel BM, Pureza VS, Pickering B, Phelan DM, Razonable RR, Rizza S, Sampathkumar P, Sanghavi DK, Sen A, Siegel JL, Singbartl K, Shah AS, Shweta F, Speicher LL, Suh G, Tabaja H Jr, Tande A, Ting HH, Tontz RC 3rd, Vaillant JJ, Vergidis P, Warsame MY, Yetmar ZA, Zomok CCD, Williams AW, Badley AD. O'Horo JC, et al. Mayo Clin Proc. 2021 Mar;96(3):601-618. doi: 10.1016/j.mayocp.2020.12.006. Epub 2020 Dec 26. Mayo Clin Proc. 2021. PMID: 33673913 Free PMC article.
Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.
Erben Y, Franco-Mesa C, Gloviczki P, Stone W, Quinones-Hinojoas A, Meltzer AJ, Lin M, Greenway MRF, Hamid O, Devcic Z, Toskich B, Ritchie C, Lamb CJ, De Martino RR, Siegel J, Farres H, Hakaim AG, Sanghavi DK, Li Y, Rivera C, Moreno-Franco P, O'Keefe NL, Gopal N, Marquez CP, Huang JF, Kalra M, Shields R, Prudencio M, Gendron T, McBane R, Park M, Hoyne JB, Petrucelli L, O'Horo JC, Meschia JF. Erben Y, et al. J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1361-1370.e1. doi: 10.1016/j.jvsv.2021.03.009. Epub 2021 Apr 6. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33836287 Free PMC article.
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19.
Ganesh R, Pawlowski CF, O'Horo JC, Arndt LL, Arndt RF, Bell SJ, Bierle DM, Borgen MD, Hanson SN, Heyliger A, Larsen JJ, Lenehan PJ, Orenstein R, Puranik A, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Razonable RR. Ganesh R, et al. J Clin Invest. 2021 Oct 1;131(19):e151697. doi: 10.1172/JCI151697. J Clin Invest. 2021. PMID: 34411003 Free PMC article.
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.
Razonable RR, Pawlowski C, O'Horo JC, Arndt LL, Arndt R, Bierle DM, Borgen MD, Hanson SN, Hedin MC, Lenehan P, Puranik A, Seville MT, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Ganesh R. Razonable RR, et al. EClinicalMedicine. 2021 Oct;40:101102. doi: 10.1016/j.eclinm.2021.101102. Epub 2021 Aug 30. EClinicalMedicine. 2021. PMID: 34485873 Free PMC article.
230 results